Navigation Links
First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease
Date:5/4/2009

nageable. Triglycerides and cholesterol were not elevated and had no negative impact on the cardiovascular safety profile. Hair growth (hirsutism) was observed in 5% of patients. Otherwise the safety profile was similar to placebo.

  • In study LX211-01 the 0.4 mg/kg BID dose fully met the primary endpoint of superiority to placebo at both weeks 16 (p=0.008) and week 24 (p=0.027) for mean change from baseline in vitreous haze, a validated measure of inflammation of the posterior segment of the eye. The magnitude of the effect was >1 step change from baseline, demonstrating a clinically relevant benefit.

  • In study LX211-02 the 0.4 mg/kg BID dose showed a reduction by 50% vs. placebo in rate of recurrence of inflammation at 6 months using a pre-specified analysis that accounted for data censoring due to non-efficacy-related discontinuations. This reduction was statistically significant (p=0.045), thus confirming the positive results from LX211-01.

  • In study LX211-03, treated patients reduced the cellular response in the front of the eye from an average of more than 25 white blood cells per high power microscopic field to an average of 6 to 10 cells per high power field. However, placebo-treated patients also improved in this study and it was therefore not possible to show that LX211 was effective for this rare subset of uveitis patients, those with refractory disease in the anterior portion of the eye.

    The LUMINATE program was conducted under the sponsorship of Lux Biosciences.


    '/>"/>

  • Contact: Joan Kureczka
    JKureczka@comcast.net
    415-821-2413
    Kureczka/Martin Associates
    Source:Eurekalert

    Page: 1 2 3 4

    Related biology technology :

    1. Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call
    2. Meso Scale Diagnostics Point of Care Influenza Test Led to the First Identification of A(H1N1) Swine Flu Infection
    3. Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009
    4. First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide
    5. Elsevier Health Sciences Appoints Dr. David Goldmann Editor-in-Chief of its First Consult Point of Care Resource
    6. The first DFG research centers to be funded for another 4 years
    7. TorreyPines Therapeutics Reports First Quarter 2009 Financial Results
    8. Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll
    9. First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals GGTI-2418
    10. United Therapeutics Reports First Quarter 2009 Financial Results
    11. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... foam of atom-thick sheets can be made to any ... Rice University. , In microscopic images, the foam ... and walls that reinforce each other. The structure consists ... of graphene oxide that self-assemble with the assistance of ... the foam could find use in structural components, as ...
    (Date:7/29/2014)... According to the new research ... (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & ... to 2018", published by MarketsandMarkets, analyzes and studies the ... North America , Europe ... Rest of the World (RoW). Browse 78 ...
    (Date:7/29/2014)... , July 29, 2014  ImmunoClin Corporation (IMCL) ... medicine, treatment of infectious diseases as well as ... and prevention of pathologies like cardiovascular disease, Alzheimer,s ... 2014, ImmunoClin Corporation will complete the strategic relocation ... D.C. , a key center of North ...
    (Date:7/29/2014)... , July 29, 2014  Sigma-Aldrich Corporation (NASDAQ: ... and energy use, increased its investment in Green Chemistry ... around the world last year, the Company announced Monday ... if Science Changed the World? The ... several honors for being a responsible corporate citizen, including ...
    Breaking Biology Technology:Tough foam from tiny sheets 2Digital Pathology Market worth $437 Million by 2018 2Digital Pathology Market worth $437 Million by 2018 3ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 2Sigma-Aldrich Achieves Record Success in Environmental, Community Initiatives 3
    ... 2011 BioStorage Technologies, Inc. a global provider ... cold chain logistics for the bioscience industry, will ... the International Contract Services Expo (ICSE), on Wednesday, ... The symposium will include two 1-hour presentations ...
    ... International, Inc. (OTC Pink: DYAI), a global biotechnology ... financial results for the third quarter ended September ... to discuss those financial results as follows: ...  After market close, Thursday, November 3, 2011. ...
    ... 2011 Verenium Corporation (Nasdaq: VRNM ), ... enzymes, today announced that it has entered into an ... the United States ("Ex-Im Bank") for two 18-month, secured ... These new credit facilities will allow the ...
    Cached Biology Technology:BioStorage Technologies to Host Global Sample Management Benchmarking Symposium at International Contract Services Expo 2Verenium Announces Up to $16 Million in New Secured Financings 2Verenium Announces Up to $16 Million in New Secured Financings 3
    (Date:7/28/2014)... Roald Amundsen reached the South Pole in 1911, but ... before any human. , Using data from 16 ice ... continent, including the South Pole, a group led by ... Reno, Nevada, created the most accurate and precise reconstruction ... The new record, described in an article published today ...
    (Date:7/28/2014)... among minerals and organic compounds in hydrothermal environments are ... provide energy for the deep biosphere, and may have ... is known about how minerals influence organic reactions. ... demonstrated how a common mineral acts as a catalysts ... for toxic solvents or expensive reagents. , At the ...
    (Date:7/28/2014)... of juvenile rat brain cells suggests that the effects ... between brain cells are temporary. , The study, published ... ONE , was conducted by biologists at the University ... in New York in response to concerns, arising from ... exposing children to general anesthetics may increase their susceptibility ...
    Breaking Biology News(10 mins):Lead pollution beat explorers to South Pole, persists today 2Lead pollution beat explorers to South Pole, persists today 3Mineral magic? Common mineral capable of making and breaking bonds 2Mineral magic? Common mineral capable of making and breaking bonds 3Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
    ... UT Southwestern Medical Center have discovered a basic mechanism ... vessels can grow ?sometimes abnormally ?suggesting methods of treatment ... blood vessels is involved in hypertension, coronary artery disease, ... this detailed mechanism, it is now possible to begin ...
    ... line that produced humans seems to be among the slowest. ... the European Molecular Biology Laboratory (EMBL), is that our species ... been lost in more quickly-evolving animals. This overturns a commonly-held ... The work appears in the current issue of the journal ...
    ... willow warblers and beaver dams once were bountiful in an ... wolves left this area, elk grew more plentiful, browsing heavily ... and sparrows have replaced the warblers in what is now ... absence of the wolf, a top predator. That's the compelling ...
    Cached Biology News:UT Southwestern researchers unravel control of growing blood vessels 2The earliest animals had human-like genes 2The earliest animals had human-like genes 3Wolves' top-down effect 2
    ... hydrolytic enzyme that catalyzes the conversion,of ... maltose, maltotriose and,dextrins. The level of ... human,body are of clinical importance,1-3 while ... for industry.4, The EnzChek Amylase Assay ...
    Rat monoclonal [20d5] to NKG2A + C+ E ( Abpromise for all tested applications). Antigen: Tissue / cell preparation (Mouse): CHO transfected cells expressing the B6 allele of NKG2A. Entrez Gen...
    ... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
    ... Forma's stainless steel rack ... adjustable mechanism that permits ... shaking angles, and "snap-in" ... universal rack holder will ...
    Biology Products: